CVS Health Corporation

CVS Health Corporation

84.17
EUR
+1.05
(+1.26%)
3.35EPS
26.96P/E
115.85BMarket Cap
Nov 04Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
104.16
120.04
137.11
165.47
181.16
186.38
197.37
205.28
221.46
245.78
278.42
296.12
317.34
326.13
Basic EPS, GAAP
3.77
4
4.68
4.96
6.49
-0.57
5.1
5.48
6.07
3.29
6.49
3.66
1.4
3.84
Free Cash Flow per Basic Share
3.12
5.17
5.52
7.38
5.97
6.54
7.99
10.26
11.94
10.25
8.09
5.02
6.16
9.24
Dividend per Share
0.9
1.11
1.41
1.71
2.01
1.95
2
2
1.99
2.22
2.44
2.68
2.68
2.68
Book Value per Share
32.15
33.3
33.78
34.71
37.17
44.96
49.05
52.97
56.79
54.98
59.36
59.97
59.18
62.36
Tangible Book Value per Share
1.58
0.04
-13.43
-14.07
-14.19
-44
-37.64
-31.53
-25.02
-24.22
-34.2
-34.15
-28.14
-23.8
Basic Weighted Avg Shares
1,217
1,161
1,118
1,073
1,020
1,044
1,301
1,309
1,319
1,312
1,285
1,259
1,267
1,273
Sales/Revenue/Turnover
126,761
139,367
153,290
177,546
184,786
194,579
256,776
268,706
292,111
322,467
357,776
372,809
402,067
415,086
Operating Margin (%)
6.34
6.31
6.18
5.85
5.26
5.23
4.76
5.18
5.17
5.05
4.08
2.6
2.58
3.38
Depreciation Expense
1,870
1,931
2,092
2,475
2,479
2,718
4,371
4,441
4,486
4,224
4,366
4,597
4,606
4,522
Net Income, GAAP
4,592
4,644
5,237
5,317
6,622
-594
6,634
7,179
8,001
4,311
8,344
4,614
1,768
4,890
Effective Tax Rate (%)
38.89
39.5
39.3
38.4
19.8
142.39
26.3
26.29
24.18
25.86
25.11
25.41
19.1
15.59
Profit Margin (%)
3.62
3.33
3.42
2.99
3.58
-0.31
2.58
2.67
2.74
1.34
2.33
1.24
0.44
1.18
Working Capital
9,900
6,956
5,989
4,792
581
1,234
-3,001
-5,648
-7,799
-3,788
-11,331
-15,964
-13,978
-11,695
LT Debt
12,841
11,630
26,267
25,615
22,181
71,444
83,625
77,964
70,148
67,276
74,672
75,426
74,145
72,434
Total Equity
37,938
37,963
37,203
36,834
37,695
58,543
64,170
69,701
75,381
71,769
76,636
75,730
75,382
79,899
Return on Invested Capital (%)
9.94
10.42
9.96
9.92
11.85
-1.73
6.2
6.66
6.59
4.01
6.9
4.04
2.4
4.42
Return on Capital (%)
9.93
9.82
9.97
9.27
11.58
-1.73
6.22
6.05
6.48
4.08
6.91
4.35
2.76
4.75
Return on Common Equity (%)
12.15
12.24
13.94
14.37
17.77
-1.24
10.87
10.77
11.08
5.88
11.28
6.07
2.35
6.23

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,805
4,484
3,872
LT Borrowings
60,502
60,531
59,452
LT Finance Leases
13,643
13,330
12,982
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,271
1,273
1,278
Market Capitalization
101,429
91,498
132,355

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
74,714
74,817
75,346
Cash, Cash Equivalents & STI
10,598
11,802
13,958
Accounts Receivable, Net
16,316
20,144
19,380
Inventories
19,246
17,770
17,622
Total Current Liabilities
88,692
86,406
87,041
Payables & Accruals
81,771
80,847
82,160
ST Debt
5,805
4,484
3,872
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.34%
1.7%
-0.46%
Free Cash Flow
6.3%
-7.15%
23.41%
Net Income, GAAP
-133.9%
-9.5%
-61.68%
Sales/Revenue/Turnover
10.39%
8.42%
7.85%
Total Cash Common Dividend
8.3%
5.38%
0.71%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
88,437
91,234
95,428
97,710
372,809
2025
94,588
98,915
102,871
105,693
402,067
2026
100,426
106,096
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.88
1.41
0.07
1.31
3.66
2025
1.41
0.81
-3.13
2.32
1.4
2026
2.31
2.33
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.67
0.68
0.66
0.67
2.68
2025
0.67
0.68
0.67
0.67
2.68
2026
0.67
0.69
- -
- -
- -

Company Description

CEO
J. David Joyner
Full Time Employees
300,000
Sector
Retail trade
Industry
Drugstore chains
Address
One CVS Drive Woonsocket RI United States 02895
IPO Date
Oct 1, 1952
Business
CVS Health Corporation (CVS) operates as a diversified health solutions provider, offering integrated pharmacy, health insurance, and care services across the United States through segments including Health Care Benefits via Aetna, Pharmacy Services via CVS Caremark, and retail pharmacy operations; core products and services encompass retail pharmacies with over 9,600 locations selling prescription drugs, over-the-counter medications, health and wellness products, and general merchandise; MinuteClinic walk-in clinics providing diagnostic testing, vaccinations, and primary care; pharmacy benefit management including formulary management, claims processing, mail-order and specialty pharmacy, infusion services, and long-term care pharmacy consulting; Aetna health insurance plans covering medical, pharmacy, dental, behavioral health, and Medicare options for employers, individuals, and government programs; CVS Specialty for complex chronic disease therapies; and digital tools like mobile apps for prescription management and virtual care. Founded in 1963 and headquartered in Woonsocket, Rhode Island, the company serves approximately 100 million consumers nationwide with a workforce exceeding 300,000 colleagues, focusing on underserved communities through in-home, in-store, and virtual services. Recent developments include the completion in October 2025 of its acquisition of select Rite Aid and Bartell Drugs assets, adding 63 stores in Idaho, Oregon, and Washington plus prescription files from 626 pharmacies across 15 states to expand access for over 9 million patients; an expanded partnership with a major insurer announced in November 2025 to enhance service integration; and ongoing investments in pharmacy workforce hiring and training amid strong third-quarter 2025 financial performance with raised full-year guidance.

Company News

  • CVS Health Corporation $CVS Shares Purchased by Cantor Fitzgerald Investment Advisors L.P.

  • Investors Purchase High Volume of Call Options on CVS Health (NYSE:CVS)

  • CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

  • How CVS' Aetna Is Advancing Efforts to Reduce Administrative Burden

  • MinuteClinic® opens three new retail medical clinics to serve Massachusetts patients

  • 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking

  • CVS Health Corporation $CVS Stock: SteelPeak Wealth LLC Raises Stake

  • Why CVS Health (CVS) is a Top Value Stock for the Long-Term

  • CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider

  • CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey

  • CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?

  • CVS to pay $315 million settlement to resolve DOJ opioid lawsuit

  • MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards

  • Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims

  • Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

  • CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

  • CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

  • CVS Stock Dips After Drop in Medicare Advantage Plan Ratings

  • At 71, She Chose Humana for the Part B Giveback in Her Social Security Check. For 2027, Humana Will Cut or Eliminate It for 62% of Those Members